Miral Health Care Executive Regulatory Affairs salaries in India

The average salary of a Executive Regulatory Affairs at Miral Health Care in India typically ranges from ₹1.8 Lakhs to ₹2.7 Lakhs per year, depending on experience (from 3 years to 4 years).

The top 10% of Executive Regulatory Affairs at Miral Health Care earn more than ₹2.7 Lakhs per year, and the top 1% earn over ₹2.7 Lakhs per year. Executive Regulatory Affairs Salaries at Miral Health Care can be higher or lower depending on factors such as the specific team, level of experience, and additional benefits like bonuses and stock options.

These estimates are based on salary data submitted by 4 Miral Health Care employees in India.

The estimated take-home salary of a Executive Regulatory Affairs at Miral Health Care in India typically ranges from ₹16,701 to ₹18,413 per month. This is based on the average salary range of ₹1.8 Lakhs to ₹2.7 Lakhs per year for employees with experience ranging from 3 years to 4 years.The take-home salary is calculated after accounting for standard deductions such as taxes, provident fund (PF), and insurance. Salary estimates are based on 4 salaries received from various employees of Miral Health Care. Check how we calculate in-hand salary with our in-hand salary calculator.

Genpact	₹3.3 Lakhs to ₹7.0 Lakhs per year
HCLTech	₹2.5 Lakhs to ₹6.3 Lakhs per year
TCS	₹1.9 Lakhs to ₹6.9 Lakhs per year
Micro Labs	₹3.0 Lakhs to ₹4.8 Lakhs per year
Jio	₹2.7 Lakhs to ₹3.1 Lakhs per year

These companies are known for offering competitive compensation packages that can exceed the salary offered by Miral Health Care, depending on the role and experience level.

The salary growth for a Executive Regulatory Affairs at Miral Health Care depends on factors such as experience, performance, and promotions. On average, a Executive Regulatory Affairs can expect the following growth trajectory at Miral Health Care:

Experience	Average Salary Range
3 years	₹2.3 Lakhs to ₹2.9 Lakhs per year
4 years	₹2.0 Lakhs to ₹2.6 Lakhs per year

and so on.